
Indo US Bio-Tech (INDOUS) Share Price Rises 18.72% Today to Rs 85.5: Price Rise Analysis
Updated: 28 Oct 2026 • 9:32 am
Posted by:

Indo US Bio-Tech Share Price moved sharply higher in early trade on 28 October 2026. Indo US Bio-Tech Ltd. was at Rs 85.5 as of 28 October 2026 at 9:23:00 AM IST, a gain of Rs 13.48 or 18.72% over the previous close of Rs 72.02. The company has a market cap of Rs 120.35 Cr and operates in the Agriculture industry within the Agri sector.
Univest figures confirm the price action, but they do not point to a specific company trigger. That matters for anyone reading Indo US Bio-Tech stock news today, because the move is a verified fact while the reason behind it is not. This Indo US Bio-Tech Share Price update therefore sticks to what the latest Univest figures show: the price action, the fundamental ratios, the sector benchmark and the peer comparison.
Indo US Bio-Tech Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 85.5 |
| Previous Close | Rs 72.02 |
| Today's Move | Rs 13.48 (+18.72%) |
| Open | Rs 83.97 |
| High | Rs 86.42 |
| Low | Rs 82 |
| Market Capitalisation | Rs 120.35 crore |
| Market Cap Category | Micro Cap |
Investors tracking Indo US Bio-Tech Share Price Today can use the sections below to see how the move sits against the company's own ratios and against listed Agriculture peers on the NSE and BSE.
Indo US Bio-Tech Ltd. (INDOUS) rose to Rs 85.5 from the previous close of Rs 72.02, a move of Rs 13.48 or 18.72%. The stock opened at Rs 83.97, reached a high of Rs 86.42, recorded a low of Rs 82.
The Indo US Bio-Tech share price rise began from the open. The stock opened at Rs 83.97, already well above the previous close of Rs 72.02, and then moved between Rs 82 and Rs 86.42. The current price of Rs 85.5 sits just under the day high of Rs 86.42 and well above the day low of Rs 82.
Put simply, the Indo US Bio-Tech Share Price Update at 9:23 AM IST shows a stock that has stayed above its previous close for the entire session so far. The gap between the day high and the day low is Rs 4.42, a narrow band next to the Rs 13.48 gain from the previous close. Market capitalisation stands at Rs 120.35 Cr, which keeps Indo US Bio-Tech a small company by absolute size.
Indo US Bio-Tech Ltd. (INDOUS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 120.35 crore |
| P/E Ratio | 12.61x |
| P/B Ratio | 1.51x |
| ROE | 15.34% |
| ROCE | 14.51% |
| EPS | Rs 5.71 |
| Book Value Per Share | Rs 47.66 |
| Dividend Yield | 0% |
Indo US Bio-Tech Ltd. (INDOUS) fundamental metrics show P/E 12.61x, P/B 1.51x, ROE 15.34%, ROCE 14.51%. Taken on their own, these numbers offer context rather than a trading signal.
Indo US Bio-Tech Ltd. has a market capitalisation of Rs 120.35 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 12.61x, P/B at 1.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.34% and ROCE of 14.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.71, book value per share of Rs 47.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 14.04x, median ROE of 9.07%, median ROCE of 10.16%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Agri |
| Industry | Agriculture |
| Benchmark Scope | same industry |
| Company P/E Ratio | 12.61x |
| Benchmark Median P/E | 14.04x |
| Benchmark Average P/E | 56.57x |
| Benchmark P/E Range | 1.05x to 604.5x |
| Company P/B Ratio | 1.51x |
| Benchmark Median P/B | 1.46x |
| Company ROE | 15.34% |
| Benchmark Median ROE | 9.07% |
| Company ROCE | 14.51% |
| Benchmark Median ROCE | 10.16% |
| Company Market Capitalisation | Rs 120.35 crore |
| Benchmark Median Market Cap | Rs 81.07 crore |
Indo US Bio-Tech Ltd. (INDOUS) operates in the Agri sector, within the Agriculture industry.
Indo US Bio-Tech Ltd. (INDOUS) has a P/E ratio of 12.61x, which is below the benchmark median of 14.04x, a difference of -10.19%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Indo US Bio-Tech Ltd. (INDOUS) has a ROE of 15.34%, which is above the benchmark median of 9.07%, a difference of +69.13%. Indo US Bio-Tech Ltd. (INDOUS) has a ROCE of 14.51%, which is above the benchmark median of 10.16%, a difference of +42.81%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bombay Burmah Trading Corporation Ltd. | BBTC | 8,090.4 | 6.37 | 1.08 | 39.44 | 44.26 |
| Kaveri Seed Company Ltd. | KSCL | 3,579.39 | 14.04 | 1.72 | 18.17 | 18.8 |
| Venky'S (India) Ltd. | VENKEYS | 2,281.23 | 13.11 | 1.38 | 9.07 | 11.92 |
| AVT Natural Products Ltd. | AVTNPL | 1,338.12 | 16.42 | 2.33 | 12.16 | 14.26 |
| REGAAL RESOURCES LIMITED | REGAAL | 911.19 | 15.23 | 1.83 | 15.26 | 11.39 |
Indo US Bio-Tech Ltd. (INDOUS) has a P/E ratio of 12.61x compared with the displayed peer median of 14.04x. The comparison is relative and should not be read as a recommendation. Its ROE of 15.34% compares with a peer median of 15.26% across the companies shown in the table. ROCE stood at 14.51% versus the displayed peer median of 14.26%, providing a capital-efficiency comparison. Indo US Bio-Tech Ltd. (INDOUS) has a market capitalisation of Rs 120.35 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Indo US Bio-Tech
- Price action: Indo US Bio-Tech Share Price rose 18.72% to Rs 85.5 from a previous close of Rs 72.02, with a day high of Rs 86.42.
- Valuation: the P/E of 12.61 is below the industry median of 14.04, while the P/B of 1.51 is close to the median of 1.46.
- Returns: ROE of 15.34% and ROCE of 14.51% are above the industry medians of 9.07% and 10.16%.
- Per-share figures: EPS is Rs 5.71 and book value is Rs 47.66, against a share price of Rs 85.5.
- Sector position: the Rs 120.35 Cr market cap is above the industry median of Rs 81.07 Cr but below every listed peer shown.
About Indo US Bio-Tech
Indo US Bio-Tech Ltd. is a listed company in the Agriculture industry, which forms part of the Agri sector. Within its benchmark group of 47 same-industry companies, it has a market cap of Rs 120.35 Cr, which is above the group median of Rs 81.07 Cr.
The company reports EPS of Rs 5.71 and book value of Rs 47.66 per share, with ROE of 15.34% and ROCE of 14.51%. Further company detail, such as segments or product mix, is not part of the figures used for this Indo US Bio-Tech company news update, so the analysis stays with verified ratios.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Indo US Bio-Tech share price rising today?
Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock was at Rs 85.5 at 9:23 AM IST, up 18.72% from the previous close of Rs 72.02.
What is Indo US Bio-Tech Share Price today?
Ans. Indo US Bio-Tech Share Price was Rs 85.5 as of 28 October 2026 at 9:23:00 AM IST. That is a gain of Rs 13.48 over the previous close of Rs 72.02, or 18.72%, with a day high of Rs 86.42.
What is the market cap of Indo US Bio-Tech?
Ans. Indo US Bio-Tech has a market capitalisation of Rs 120.35 Cr. The median market cap across the 47 companies in its Agriculture industry benchmark is Rs 81.07 Cr, so the company sits above that median.
What are the day high and day low for Indo US Bio-Tech Share Price?
Ans. The stock opened at Rs 83.97 and touched a high of Rs 86.42 and a low of Rs 82 as of 9:23 AM IST. The current price of Rs 85.5 sits just below the day high.
What is the P/E ratio of Indo US Bio-Tech?
Ans. The P/E ratio is 12.61, below the industry benchmark median of 14.04 across 37 companies. The P/B ratio is 1.51 against a median of 1.46, so the company is valued close to the benchmark on book value.
What are the ROE and ROCE of Indo US Bio-Tech?
Ans. ROE is 15.34% and ROCE is 14.51%. Both are above the Agriculture industry medians of 9.07% and 10.16%, based on the latest Univest benchmark of 45 same-industry companies with reported returns.
What are the EPS and book value of Indo US Bio-Tech?
Ans. EPS is Rs 5.71 and book value is Rs 47.66 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share, against a price of Rs 85.5.
How does Indo US Bio-Tech compare with its peers?
Ans. The company has a P/E of 12.61, lower than four of the five peers shown, and a market cap of Rs 120.35 Cr, smaller than all five. ROE of 15.34% is above three of those peers.
Track Indo US Bio-Tech Share Price on Univest
Use Indo US Bio-Tech Ltd. (INDOUS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest lets users track the live Indo US Bio-Tech Share Price, fundamental ratios, 52-week levels and market insights for Indo US Bio-Tech in one place. The same page shows P/E, P/B, ROE and ROCE, so the figures in this article can be rechecked as the session moves. Univest market updates also cover other stocks rising today and the wider Indian stock market.
This article is informational and does not recommend any action on Indo US Bio-Tech Share Price.
Recent Articles

Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
19 November 2026

Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
19 November 2026

Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
19 November 2026

Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
HGS (INDIA) LIMITED Hits Upper Circuit on NSE, 19 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





